This Thanksgiving, instead of turkeys, think of ducks — and “wascally wabbits,” as MeTV Toons airs over 12 full hours of classic Looney Tunes featuring Daffy Duck and Bugs Bunny as part of their ...

Investing.com - Goldman Sachs has reiterated its Buy rating and $8.00 price target on Gossamer Bio Inc. (NASDAQ:GOSS), currently ...

SAN DIEGO, November 05, 2025--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for ...

SAN DIEGO (AP) — SAN DIEGO (AP) — Gossamer Bio Inc. (GOSS) on Wednesday reported a loss of $48.2 million in its third quarter. On a per-share basis, the San Diego-based company said it had a loss of ...

Visitors to the Looney House this weekend found no bullet holes in the walls, no skeletons in the basement, and although there have been rumors of tunnels that lead out of the house to nearby homes, ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

Investing.com - Cantor Fitzgerald has maintained its Overweight rating on Gossamer Bio Inc. (NASDAQ:GOSS) as the company’s seralutinib clinical trial approaches a significant milestone. The stock, ...

Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, ...